Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of August 13, 2025 • 3:30 AM ET

Date/Time Source News Release
08/07/2025 07:30 AM EDT GlobeNewswire Cabaletta Bio Reports Second Quarter 2025 Financial Results and Provides Business Update
06/11/2025 09:54 AM EDT GlobeNewswire Cabaletta Bio Announces Pricing of Public Offering of Securities
06/11/2025 06:15 AM EDT GlobeNewswire Cabaletta Bio Announces Proposed Public Offering of Securities
06/11/2025 06:00 AM EDT GlobeNewswire Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress
05/29/2025 08:00 AM EDT GlobeNewswire Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference
05/15/2025 07:00 AM EDT GlobeNewswire Cabaletta Bio Announces 2027 Rese-cel BLA Submission Anticipated in Myositis Following Recent FDA Alignment on Registrational Cohorts
03/31/2025 07:00 AM EDT GlobeNewswire Cabaletta Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
03/19/2025 07:00 AM EDT Business Wire Cellares and Cabaletta Bio Successfully Complete Manufacturing Technology Adoption Program for Rese-cel Using the Cell Shuttle(TM) Platform
02/26/2025 08:00 AM EST GlobeNewswire Cabaletta Bio to Participate in the TD Cowen 45th Annual Health Care Conference
02/18/2025 10:21 AM EST GlobeNewswire UPDATE - Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings
Page

Additional News

As of August 13, 2025 • 3:30 AM ET

Date/Time Source News Release
08/11/2025 12:00 PM EDT Zacks Cabaletta Bio (CABA) Upgraded to Buy: Here's Why
08/08/2025 05:31 AM EDT US Earnings Reports Expected earnings - Cabaletta Bio Inc.
08/07/2025 12:49 PM EDT SeekingAlpha Cabaletta Bio files $240M mixed securities shelf
06/11/2025 10:09 AM EDT SeekingAlpha Cabaletta Bio announces pricing of public offering of securities; shares decline over 28%
06/11/2025 09:49 AM EDT SeekingAlpha Cabaletta Bio: Sector Headwinds And Funding Issues... But Also Some Clear Clinical Direction
06/11/2025 06:29 AM EDT SeekingAlpha Cabaletta Bio slides on proposed securities offering
06/06/2025 11:09 AM EDT SeekingAlpha Autolus: A Buy Before Key Data Readout, Potential Expansion Into Autoimmune Market
05/17/2025 05:31 AM EDT US Earnings Reports Expected earnings - Cabaletta Bio Inc.
03/31/2025 07:57 AM EDT SeekingAlpha Cabaletta Bio GAAP EPS of -$0.65
03/27/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, March 27th, 2025
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.